Browse > Article

Evaluation of Safety of Streptococcus pneumoniae DNA Vaccine in Immunopathological Aspect  

Lee Jue-Hee (College of Pharmacy, Dongduk Women's University)
Han Yongmoon (College of Pharmacy, Dongduk Women's University)
Publication Information
YAKHAK HOEJI / v.50, no.1, 2006 , pp. 33-39 More about this Journal
Abstract
We have previously reported the minimum criteria that can be applied to evaluate efficacy and safety of a DNA vaccine with use of Streptococcus pneumoniae DNA vaccine (SPDNA). The SPDNA was formulated by inserting the DNA sequences that are codons specific for the carbohydrate epitope in the capsule of S. penumoniae by phage display peptide library. Administration of the SPDNA into mice induced both humoral and cell-mediated immunities. The induction was protective even in the absence of CD4+ T lymphocyte in mice. Profiles of cytokine and isotyping of antibody displayed tendency of the Th1. In continuation of these studies, we examined if the efficacy of the SPNDA was provoked by the peptide recognized by codons specific for the capsule. Results showed that the peptide vaccine formulae (SPP) induced protective antibody in mice as did the SPDNA. Involvement of the cell-mediated immunity was also determined. Possible side effects of autoimmune diseases such as myositis and C3a production and tumor-formation were undetectable in mice given 7 times of SPDNA vaccination during entire of 92 days. Even after the frequent immunization, immunogenicity of the SPDNA was observed as determined for antibody production, suggesting that there was no immunotolerance provoked. All together, these examining factors would be applied to measurement of a DNA vaccine safety regarding the immunopathological aspect.
Keywords
DNA vaccine; S. pneumoniae; safety; autoimmune; tolerance; mice;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Donnelly, J. J., Ulmer, J. B., Shiver, J. W. and Liu, M. A. : DNA vaccines. Ann. Rev. Immunol. 15, 617 (1997)   DOI   ScienceOn
2 Wolff, J. A. and Budker, V. : The mechanism of naked DNA uptake and expression. Adv. Genet. 54, 13 (2005)
3 Rice, J., Buchan, S., Dewchand, H., Simpson, E. and Stevenson, F. K. : DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire. J. Immunol. 173(7), 4492 (2004)   DOI
4 Edmonson, H. A. and Steiner, P. E. : Primary carcinoma of the liver: a study of 100 cases among 48,900 necrosis. Cancer. 7, 462 (1954)   DOI   ScienceOn
5 Han, Y. and Lee, J. : A pneomococcal conjugate vaccine formula induces protection in mice against disseminated disease due to Streptococcus pneumoniae. Yakhak Hoeji 48, 345 (2004)
6 Lee, J.-H. and Han, Y. : Evaluation of a Streptococcus pneumoniae DNA vaccine efficacy. Yakhak Hoeji 49, 484 (2005)
7 Ellenberg, S. S. and Chen, R. T. : The complicated task of monitoring vaccine safety. Public Health Rep. 112, 10 (1997)
8 Gregory, B., Lesinski, S., Smithson, L., Srivastava, N., Chen, D., Widera, G. and Westerink, J. : A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine. 19, 1717 (2001)   DOI   ScienceOn
9 Lee, J. and Han, Y. : Antibody induced by the JY-Pol pneumococcal conjugate protects mice against systemic infection due to Streptococcus pneumoniae. Yakhak Hoeji 48, 369 (2004)
10 Karin, N. : Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines. Curr. Opin. Mol. Ther. 6(1), 27 (2004)
11 Bosarge, J. R., Watt, J. M., McDaniel, D. O., Swiatlo, E. and McDaniel, L. S. : Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Infect. Immun. 69(9), 5456 (2001)   DOI   ScienceOn
12 Tidball, J. G. and Wehling-Henricks, M. : Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis. Curr. Opin. Rheumatol. 17, 707 (2005)   DOI   ScienceOn
13 Abraham, S,. Begum, S. and Isenberg D. : Hepatic manifestations of autoimmune rheumatic diseases. Ann. Rheum. Dis. 63, 123 (2004)   DOI   ScienceOn
14 Rose, M. A., Schubert, R., Strnad, N. and Zielen, S. : Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine. Clin Diagn Lab. Immunol. 12, 1216 (2005)
15 Marsac, D., Puaux, A. L., Riviere, Y. and Michel, M. L. : In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/ hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice. Immunobiology 210(5), 305 (2005)
16 Donnelly, J. J., Ulmer, J. B. and Liu, M. A. : DNA vaccines. Dev. Biol. Stand. 95, 43 (1998)
17 von Herrath, M. G. and Bot, A. : Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms. Trends Immunol. 24(6), 89 (2003)
18 Ogunniyi, A. D., Giammarinaro, P. and Paton, J. C. : The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiolog, 148, 2045 (2001)
19 Wong, S. F. : Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Clin. Ther. 27(6), 684 (2005)   DOI   ScienceOn
20 Cichutek, K. : DNA vaccines: development, standardization and regulation. Intervirology 43, 331 (2000)   DOI   ScienceOn
21 Whitney, C. G. : Impact of conjugate pneumococcal vaccines. Pediatr. Infect Dis. J. 24, 729 (2005)   DOI   ScienceOn
22 Klinman, D. M., Takeshita, F., Kamstrup, S., Takeshita, S., Ishii, K., Ichino, M. and Yamada, H. : DNA vaccines: capacity to induce auto-immunity and tolerance. Dev. Biol. (Basel) 104, 45 (2000)
23 Quigg, R. J. : Complement and autoimmune glomerular diseases. Curr. Dir. Autoimmun. 7, 165 (2004)